Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘16
151
17 24 7 14.3%
152
17 89 72 46.4%
153
17 23 6 5.72%
LCTX icon
154
Lineage Cell Therapeutics
LCTX
$377M
17 27 10 51.6%
155
17 61 44 36.1%
156
17 37 20 0.25%
157
17 34 17 32.3%
158
17 48 31 20.5%
159
17 30 13 61.9%
160
17 28 11 39.9%
FIVN icon
161
FIVE9
FIVN
$1.67B
17 58 41 37.5%
162
17 31 14 20.1%
163
17 55 38 43.7%
164
16 40 24 16.7%
165
16 63 47 11.5%
166
16 37 21 31.8%
167
16 88 72 55.9%
168
16 37 21 26.7%
169
16 77 61 72.2%
170
16 27 11 20.8%
171
16 29 13 57.7%
172
16 31 15 132%
173
16 43 27 103%
174
16 55 39 47.8%
175
16 54 38 24.5%